Full-Time

Scientist I/II

Vector & Molecular Biology

Posted on 10/4/2024

Tr1X

Tr1X

11-50 employees

Develops cellular immunotherapies for autoimmune diseases

Biotechnology
Healthcare

Junior, Mid

No H1B Sponsorship

San Diego, CA, USA

Category
Biology Lab & Research
Biology & Biotech
Required Skills
Data Analysis
Requirements
  • A PhD in molecular biology, biochemistry, virology, microbiology, or related field with a 2+ years of relevant industry experience
  • Strong expertise in the design, execution, and validation of CRISPR/Cas9 gene editing experiments (knock-outs and knock-ins)
  • Expertise in molecular cloning techniques (PCR, Restriction digesting, Gibson/Infusion assembly, gel electrophoresis, plasmid prepping)
  • Skilled with primer design, Sanger sequencing, and molecular biology and sequence analysis software, such as SnapGene.
  • Experience with western blotting or similar protein expression assays
  • Expertise in multicolor flow cytometry in primary cells and analysis
  • Experience with GraphPad Prism and Microsoft Office Suite programs for data analysis, presentations and report and protocol writing.
  • High-level capability with mammalian tissue culture and primary T-cell culture
  • Ability to interpret results analytically in a timely manner and troubleshoot technical problems.
  • Great attention to detail. Agile and flexible mindset yet highly organized.
  • Ability to prioritize multiple tasks, work under various timeline pressures, drive tasks to completion, and anticipate and proactively develop mitigation strategies.
  • Previous experience with electronic lab notebooks (ELN).
  • The ability to perform in a start-up environment.
Responsibilities
  • Build – a robust cell engineering infrastructure to enable proof-of-concept experiments in primary immune cells
  • Perform over-expression, knock-out, and knock-in experiments in cell culture and primary cells
  • Design and produce expression and viral plasmids in support of program goals.
  • Maintain detailed and highly organized documentation of experimental procedures, SOPs, data, and generated products.
  • Analyze data in a timely manner and present findings at team/departmental meetings.
  • Demonstrate advanced knowledge of principles and techniques in molecular cloning, gene editing, and cell culture
  • Keep up to date - on industry knowledge and advancements; provide input on optimization of design, process, or capability.
  • Contribute – Be a subject matter expert and contribute to project direction, prioritization and mitigation strategies.
  • Mentor junior Research Associates to help them reach the next level
  • Collaborate - and work effectively with Discovery Biology, Translational Sciences and CMC teams.

Tr1X focuses on developing cellular immunotherapies aimed at treating autoimmune and inflammatory diseases. The company uses a proprietary platform to create cell therapy products that help to rebalance the immune system and restore balance within the body, which can lead to long-term tolerance of the immune response. Unlike many competitors, Tr1X emphasizes the creation of first-in-class therapies specifically designed to address these complex conditions. The goal of Tr1X is to provide advanced therapeutic solutions that improve the quality of life for patients suffering from these diseases.

Company Stage

Series A

Total Funding

$73M

Headquarters

San Diego, California

Founded

2018

Growth & Insights
Headcount

6 month growth

3%

1 year growth

36%

2 year growth

36%
Simplify Jobs

Simplify's Take

What believers are saying

  • FDA clearance of TRX103 IND accelerates proof-of-concept data collection.
  • $75M Series A funding supports rapid development of cell therapies.
  • Scalable platform allows efficient pipeline expansion beyond initial indications.

What critics are saying

  • Emerging competition in allogeneic T-cell therapy could impact market share.
  • High manufacturing costs may pose financial challenges for scalability.
  • Potential delays in clinical trials could affect product development timelines.

What makes Tr1X unique

  • Tr1X uses a proprietary platform for novel cellular immunotherapies.
  • Their focus is on allogeneic regulatory T-cell therapies for autoimmune diseases.
  • Tr1X's TRX103 is the first allogeneic engineered Tr1 regulatory T cell product.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE